13 research outputs found
Recommended from our members
Polymorphisms in the Gene That Encodes the Iron Transport Protein Ferroportin 1 Influence Susceptibility to Tuberculosis
Background: We studied the association between iron intake and polymorphisms in the iron transporter gene, SLC40A1, and the risk of tuberculosis. Methods: We compared iron intake, the frequency of SLC40A1 mutations, and interactions between these variables among 98 TB patients and 125 controls in Kwazulu-Natal, South Africa. Results: Four SLC40A1 SNPs were associated with an increased risk of tuberculosis and one with reduced risk. We also found a gene-environment interaction for four non-exonic SNPs and iron intake. Conclusions: This pilot study demonstrated an association between polymorphisms in SLC40A1 and tuberculosis and provided evidence for an interaction between dietary iron and SLC40A1.Organismic and Evolutionary Biolog
Target (MexB) and efflux based mechanisms decreasing the effectiveness of the efflux pump inhibitor D13-9001 in P. aeruginosa PAO1: uncovering a new role for MexMN-OprM in efflux of β-lactams and a novel regulatory circuit controlling MexMN expression
Efflux pumps contribute to antibiotic resistance in Gram-negative pathogens.
Correspondingly, efflux pump inhibitors (EPIs) may reverse this resistance. D13-
9001 specifically inhibits MexAB-OprM in Pseudomonas aeruginosa. Mutants with decreased
susceptibility to MexAB-OprM inhibition by D13-9001 were identified, and these
fell into two categories: those with alterations in the target MexB (F628L and ΔV177)
and those with an alteration in a putative sensor kinase of unknown function, PA1438
(L172P). The alterations in MexB were consistent with reported structural studies of the
D13-9001 interaction with MexB. The PA1438L172P alteration mediated a �150-fold upregulation
of MexMN pump gene expression and a �50-fold upregulation of PA1438
and the neighboring response regulator gene, PA1437. We propose that these be renamed
mmnR and mmnS for MexMN regulator and MexMN sensor, respectively. MexMN
was shown to partner with the outer membrane channel protein OprM and to pump
several ďż˝-lactams, monobactams, and tazobactam. Upregulated MexMN functionally replaced
MexAB-OprM to efflux these compounds but was insusceptible to inhibition by
D13-9001. MmnSL172P also mediated a decrease in susceptibility to imipenem and biapenem
that was independent of MexMN-OprM. Expression of oprD, encoding the uptake
channel for these compounds, was downregulated, suggesting that this channel is also
part of the MmnSR regulon. Transcriptome sequencing (RNA-seq) of cells encoding
MmnSL172P revealed, among other things, an interrelationship between the regulation of
mexMN and genes involved in heavy metal resistance
Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection
To exploit contemporary sequencing technologies for targeted genetic analyses, we developed a hybridization enrichment strategy for DNA capture that uses PCR products as subgenomic traps. We applied this strategy to 115 kilobases of the human genome encompassing 47 genes implicated in cardiovascular disease. Massively parallel sequencing of captured subgenomic libraries interrogated 99.8% of targeted nucleotides >or=20 times ( approximately 40,000-fold enrichment), enabling sensitive and specific detection of sequence variation and copy-number variatio
Polymorphisms in the Gene That Encodes the Iron Transport Protein Ferroportin 1 Influence Susceptibility to Tuberculosis
Les sols des forêts résineuses des Basses-Vosges
The development of molecular diagnostics that detect both the presence of Mycobacterium tuberculosis in clinical samples and drug resistance-conferring mutations promises to revolutionize patient care and interrupt transmission by ensuring early diagnosis. However, these tools require the identification of genetic determinants of resistance to the full range of antituberculosis drugs
Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection
Evaluation of Second-Generation Sequencing of 19 Dilated Cardiomyopathy Genes for Clinical Applications
Medical sequencing for diseases with locus and allelic heterogeneities has been limited by the high cost and low throughput of traditional sequencing technologies. “Second-generation” sequencing (SGS) technologies allow the parallel processing of a large number of genes and, therefore, offer great promise for medical sequencing; however, their use in clinical laboratories is still in its infancy. Our laboratory offers clinical resequencing for dilated cardiomyopathy (DCM) using an array-based platform that interrogates 19 of more than 30 genes known to cause DCM. We explored both the feasibility and cost effectiveness of using PCR amplification followed by SGS technology for sequencing these 19 genes in a set of five samples enriched for known sequence alterations (109 unique substitutions and 27 insertions and deletions). While the analytical sensitivity for substitutions was comparable to that of the DCM array (98%), SGS technology performed better than the DCM array for insertions and deletions (90.6% versus 58%). Overall, SGS performed substantially better than did the current array-based testing platform; however, the operational cost and projected turnaround time do not meet our current standards. Therefore, efficient capture methods and/or sample pooling strategies that shorten the turnaround time and decrease reagent and labor costs are needed before implementing this platform into routine clinical applications